VBI Vaccines Inc/BC Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
VBI Vaccines Inc/BC quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2015 to Q4 2023.
  • VBI Vaccines Inc/BC Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $109M, a 10.6% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $109M +$10.4M +10.6% Dec 31, 2023 10-K 2024-04-16
Q4 2022 $98.1M +$11.8M +13.6% Dec 31, 2022 10-K 2024-04-16
Q4 2021 $86.4M +$15.9M +22.6% Dec 31, 2021 10-K 2023-03-13
Q4 2020 $70.5M +$16.1M +29.7% Dec 31, 2020 10-K 2022-03-07
Q4 2019 $54.3M +$12.8M +30.8% Dec 31, 2019 10-K 2021-03-02
Q4 2018 $41.6M +$9.7M +30.4% Dec 31, 2018 10-K 2020-03-05
Q4 2017 $31.9M +$3.14M +10.9% Dec 31, 2017 10-K 2019-02-25
Q4 2016 $28.7M +$23M +406% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $5.68M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.